22984 Investors following Biocon. Share this News with them.
0
Like this story, share it with millions of investors on M3
Biocon Q2 cons net profit up 23% at Rs 86 cr QoQ
Pharmaceutical firm Biocon has reported a consolidated net profit of Rs 86 crore in the quarter ended September 2011, a growth of 23% as compared to Rs 70 crore in the previous quarter.
Pharmaceutical firm Biocon has reported a consolidated net profit of Rs 86 crore in the quarter ended September 2011, a growth of 23% as compared to Rs 70 crore in the previous quarter.
Consolidated revenue jumped 18% to Rs 524 crore from Rs 443 crore during the same period.
